New faces as Leeds BRC appoints new colleagues to musculoskeletal research and EDI positions
NIHR Leeds BRC has appointed new co-leads to its musculoskeletal theme workstreams and in our EDI (Equality, Diversity and Inclusion) and Research Culture …
NIHR Leeds BRC has appointed new co-leads to its musculoskeletal theme workstreams and in our EDI (Equality, Diversity and Inclusion) and Research Culture …
Researchers at the NIHR Leeds Biomedical Research Centre (BRC) and the University of Leeds have led an innovative new project studying how to bridge the gap between patients with PMR (Polymyalgia Rheumatica) in the North of England and healthcare services.
NIHR Leeds Biomedical Research Centre is partnering on a new international, EU-backed initiative using AI and the latest big data technologies to improve care and research for people living with Osteoarthritis.
NIHR Leeds BRC was represented by several distinguished colleagues in research at the recent Lady Mayor’s Show in London.
Congratulations to Dr Jake Weddell, Academic Research Fellow in Rheumatology for winning the abstract competition in the Clinical Category at the 11th BRITSpA (British Society for Spondylarthritis) Annual Scientific Meeting.
We are proud to shine a light on some of the excellent work ongoing at NIHR Leeds Biomedical Research Centre (BRC) as part …
The NIHR Leeds Biomedical Research Centre is delighted to invite applications for the 2025-26 Post-Doctoral Clinical Research Awards.
Survival rates for people with myeloma, a type of blood cancer, have nearly doubled in recent years, according to new research led by the University of York.
Landmark research published in Nature, supported by NIHR Leeds Biomedical Research Centre, has identified a previously overlooked type of circular DNA that may play a role in post-treatment recurrence in the most common form of childhood leukaemia.
A trial supported by NIHR Leeds BRC into removing incorrect penicillin allergy labels on GP records could combat antibiotic resistance and save lives, an NIHR-funded clinical trial led by the University of Leeds has found.